Maverick Biomaterials ISO 13485 Certified
9th February 2012. Maverick Biomaterials was today awarded ISO 13485:2003 certified by BSI, valid to 8th February 2015.
Read MoreAQIS intermediate product listing Approved
Subsequent to a recent AQIS Audit Maverick has been granted Intermediate Products listing to the EU. Approval was granted 25th January 2012.
Read MoreAQIS intermediate product listing, for Biological Export to the EU, Imminent
Maverick recently received an audit by Australian Quarantine Inspection Services (AQIS) personnel with regard to attaining listing as an exporter of “intermediate Products” to the EU. Listing is expected within the month, therefore easing constraints on exporting of processed biological […]
Read MoreMaverick Biomaterials Recommended for 13485 Certification
Maverick Biomaterials Pty Ltd, producer of cross linked GBR1 bovine pericardium in Australia and New Zealand, was audited on 23rd November by BSi for ISO 13485 Certification. This certification will optimise Maverick Biomaterials production and export of cross linked GBR1 […]
Read MoreMaverick Biomaterials Progressing towards 13485 Certification.
Maverick Biomaterials is making solid progress towards probable attainment of ISO 13485 certification for Q1 2012. A Notify body audit will be completed late in the year with Mavericks Quality Manager quietly confident of a successful outcome. This will be […]
Read MoreMaverick Biomaterials continued success with 3 Dimensional (3D) fixation (glutaraldehyde cross – linking) of bovine – porcine pericardium
Maverick Biomaterials is continuing to advance its IP portfolio with regard to 3 Dimensional (3D) fixation of specifically sourced raw pericardium from it supplier Maverick Biosciences. Recent production for a range of global clients has been well received, with Maverick Biomaterials […]
Read More12 Monthly Surveillance Audit by DNV
13th January 2011, Maverick Biosciences Limited and Maverick Biosciences (NZ) Limited today received a surveillance audit by Det Norske Veritas. There were no ‘Non Conformities’ found in either minor or major categories, 1 observation was noted. The Quality Management system […]
Read MoreISO.9001:2008 Certification
11th January 2010. Maverick Biosciences Pty Limited and Maverick Biosciences (NZ) Limited was today awarded ISO.9001:2008 certification by Det Norske Veritas, valid until 2013. It has been a very pleasing outcome in that our investment in a Quality Management infrastructure […]
Read MoreSupremely customised pericardium production trial begins
In June 2009 Maverick commenced a 3 month trial production of pericardium against very tightly defined specifications, targeting achievement of a significant increase in the overall yields experienced by our manufacturing client. Mavericks remote production team has been completely trained […]
Read MoreGlutaraldehyde processing work commences in Dubbo, Australia
Maverick has been working with a number of start-up clients to resolve their need for “backroom” processing activities to be undertaken as an outsourced function so as to reduce their infrastructural investment and provide them more time and focus on […]
Read MoreNew Zealand production of device tissues commenced on an ongoing basis
After completion of a number of validation shipments Maverick New Zealand has commenced ongoing production of device tissues this month against a clients need for a dual sourced supply chain to meet regulatory requirements, and board directives to manage disease […]
Read MoreMaverick to produce sized porcine leaflets
Maverick has this week, drafted a project plan for the production and selection of sized porcine leaflets, for fixation in Australia, prior to export. Expanding upon its success in the bovine and equine tissues area, Maverick has built a project […]
Read More